Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
暂无分享,去创建一个
Q. Ou | Yongbin Zeng | Ling Jiang | Tianbin Chen | Can Liu | Jinlan Huang | N. Lin | Songhang Wu | Yuhai Hu | F. Fang | Ya Fu | Hongyan Guo | Xialin Xiao | Ni Lin
[1] Fang Wang,et al. c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA , 2021, Cell Death & Disease.
[2] S. Ficarro,et al. BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage , 2021, Nature Communications.
[3] Hui Zhang. Regulation of DNA Replication Licensing and Re-Replication by Cdt1 , 2021, International journal of molecular sciences.
[4] G. Cao,et al. Compartmentalized evolution of hepatitis B virus contributes differently to the prognosis of hepatocellular carcinoma. , 2020, Carcinogenesis.
[5] P. Marcellin,et al. Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase , 2020, Hepatology.
[6] C. Winkler,et al. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways , 2020, Viruses.
[7] Q. Ou,et al. Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients , 2020, Emerging microbes & infections.
[8] A. Danckaert,et al. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis , 2019, Gut.
[9] Y. Fujiwara,et al. HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma , 2019, International journal of molecular sciences.
[10] L. Sticchi,et al. A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals , 2019, International journal of environmental research and public health.
[11] F. Ceccherini‐Silberstein,et al. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] Mingxiong Guo,et al. Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR‐192‐3p‐XIAP Through NF kappa B Signaling , 2019, Hepatology.
[13] Ding‐Shinn Chen,et al. Hepatitis B virus infection , 2018, Nature Reviews Disease Primers.
[14] E. Hildt,et al. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection , 2018, Alimentary pharmacology & therapeutics.
[15] Lei Zheng,et al. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma , 2018, Molecular Cancer.
[16] Fu-Sheng Wang,et al. Current advances in the elimination of hepatitis B in China by 2030 , 2017, Frontiers of Medicine.
[17] K. Aird,et al. Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer , 2017, Front. Oncol..
[18] F. Sanai,et al. Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients , 2017, Oncotarget.
[19] Thomas Berg,et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.
[20] J. Kao,et al. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. , 2017, Best practice & research. Clinical gastroenterology.
[21] Ming-jie Wang,et al. Characteristics of CpG Islands and their quasispecies of full-length hepatitis B virus genomes from patients at different phases of infection , 2016, SpringerPlus.
[22] M. Yuen,et al. Hepatitis B virus full‐length genomic mutations and quasispecies in hepatocellular carcinoma , 2016, Journal of gastroenterology and hepatology.
[23] Bum-Joon Kim,et al. X region mutations of hepatitis B virus related to clinical severity. , 2016, World journal of gastroenterology.
[24] J. Jia,et al. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia , 2016, Hepatology International.
[25] Yulan Wang,et al. HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis. , 2016, Molecular and clinical oncology.
[26] S. Lee,et al. Hepatitis B virus X protein enhances Myc stability by inhibiting SCFSkp2 ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis , 2016, Oncogene.
[27] J. Zucman‐Rossi,et al. Mechanisms of HBV-induced hepatocellular carcinoma. , 2016, Journal of hepatology.
[28] P. Revill,et al. Overview of hepatitis B viral replication and genetic variability. , 2016, Journal of hepatology.
[29] Davey M. Smith,et al. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. , 2016, Cancer letters.
[30] F. Liu,et al. Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection , 2015, Journal of Clinical Microbiology.
[31] S. Mitani,et al. Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans , 2012, Proceedings of the National Academy of Sciences.
[32] C. Hannoun,et al. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[33] C. Lee,et al. Hepatitis B virus X gene and hepatocarcinogenesis , 2011, Journal of Gastroenterology.
[34] Yin Jiang,et al. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy , 2011, Gut.
[35] De-min Yu,et al. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy. , 2009, Journal of hepatology.
[36] M. Sugiyama,et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. , 2009, Gastroenterology.
[37] M. Zheng,et al. Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint. , 2008, European journal of cancer.
[38] Yang Zhang,et al. I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.
[39] E. Domingo,et al. Quasispecies and its impact on viral hepatitis , 2007, Virus Research.
[40] Chien-Jen Chen,et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. , 2005, Journal of the National Cancer Institute.
[41] C. Bréchot,et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. , 2001, Cancer research.
[42] J. Diao,et al. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. , 2001, Cytokine & growth factor reviews.
[43] C. Harris,et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Teo,et al. Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents , 1997, Journal of viral hepatitis.
[45] M. Dumont,et al. European Association for the Study of the Liver , 1971 .